RESUMEN
Melanin is a group of natural pigments that determines the human skin color and provides fundamental protection against the harmful impacts of physical and chemical stimuli. The aim of this study was to establish the regulatory role of aryl hydrocarbon receptor (AhR) in α-melanocyte-stimulating hormone (α-MSH) induced melanogenesis. In the present study, following knockdown of AhR, murine B16F10 cells were treated with α-MSH (200 nM) and tyrosinase activities, cellular melanin content, mRNA levels of several important genes involved in melanogenesis including AhR, CTNNB1, TYR2, and microphthalmia-associated transcription factor (MITF) were measured as endpoints. Exposure to α-MSH led to elevated expression of AhR, CTNNB1, MITF, and TYR in accordance with increased tyrosinase enzyme activity as well as a significant rise in the total melanin content. Our results suggest that AhR plays a regulatory role in α-MSH-stimulated melanogenesis.
Asunto(s)
Melaninas/biosíntesis , Hormonas Estimuladoras de los Melanocitos/metabolismo , Hormonas Estimuladoras de los Melanocitos/farmacología , Melanocitos/metabolismo , Melanoma/fisiopatología , Receptores de Hidrocarburo de Aril/efectos de los fármacos , Proteínas Represoras/metabolismo , Animales , Modelos Animales de Enfermedad , Regulación Neoplásica de la Expresión Génica , Humanos , Hormonas Estimuladoras de los Melanocitos/genética , Redes y Vías Metabólicas/efectos de los fármacos , Ratones , Células Tumorales Cultivadas/efectos de los fármacosRESUMEN
The genetic origin of human skin pigmentation remains an open question in biology. Several skin disorders and diseases originate from mutations in conserved pigmentation genes, including albinism, vitiligo, and melanoma. Teleosts possess the capacity to modify their pigmentation to adapt to their environmental background to avoid predators. This background adaptation occurs through melanosome aggregation (white background) or dispersion (black background) in melanocytes. These mechanisms are largely regulated by melanin-concentrating hormone (MCH) and α-melanocyte-stimulating hormone (α-MSH), two hypothalamic neuropeptides also involved in mammalian skin pigmentation. Despite evidence that the exogenous application of MCH peptides induces melanosome aggregation, it is not known if the MCH system is physiologically responsible for background adaptation. In zebrafish, we identify that MCH neurons target the pituitary gland-blood vessel portal and that endogenous MCH peptide expression regulates melanin concentration for background adaptation. We demonstrate that this effect is mediated by MCH receptor 2 (Mchr2) but not Mchr1a/b. mchr2 knock-out fish cannot adapt to a white background, providing the first genetic demonstration that MCH signaling is physiologically required to control skin pigmentation. mchr2 phenotype can be rescued in adult fish by knocking-out pomc, the gene coding for the precursor of α-MSH, demonstrating the relevance of the antagonistic activity between MCH and α-MSH in the control of melanosome organization. Interestingly, MCH receptor is also expressed in human melanocytes, thus a similar antagonistic activity regulating skin pigmentation may be conserved during evolution, and the dysregulation of these pathways is significant to our understanding of human skin disorders and cancers.
Asunto(s)
Hormonas Hipotalámicas/metabolismo , Melaninas/metabolismo , Hormonas Hipofisarias/metabolismo , Pigmentación de la Piel/genética , Animales , Hormonas Hipotalámicas/genética , Hipotálamo/citología , Hipotálamo/metabolismo , Melaninas/genética , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , Melanocitos/metabolismo , Neuronas/metabolismo , Hormonas Hipofisarias/genética , Pez CebraRESUMEN
We investigated the effects of tank brightness on body color, growth, and endocrine systems of rainbow trout (Oncorhynchus mykiss). Five different tank colors that produce varying levels of brightness were used, including black, dark gray [DG], light gray [LG], white, and blue. The fish were reared in these tanks for 59 days under natural photoperiod and water temperature. The body color was affected by tank brightness, such that body color brightness was correlated with tank brightness (white-housed ≥ LG-housed ≥ DG-housed ≥ blue-housed ≥ black-housed). No difference in somatic growth was observed among the fish reared in the five tanks. The mRNA levels of melanin-concentrating hormone (mch1) was higher in white-housed fish than those in the other tanks, and the mRNA levels of proopiomelanocortins (pomc-a and pomc-b) were higher in fish housed in a black tank than those in other tanks. mRNA level of somatolactin, a member of growth hormone family, was higher in black-housed fish than those in white-housed fish. The mRNA levels of mch1 and mch2 in blue-housed fish were similar to those in black-housed fish, while the mRNA levels of pomc-a and pomc-b in blue-housed fish were similar to those in white-housed fish. The current results suggest that tank color is not related to fish growth, therefore any color of conventional rearing tank can be used to grow fish. Moreover, the association between somatolactin with body color changes is suggested in addition to the role of classical MCH and melanophore stimulating hormone derived from POMC.
Asunto(s)
Sistema Endocrino/metabolismo , Oncorhynchus mykiss/crecimiento & desarrollo , Pigmentación , Animales , Color , Hormona del Crecimiento/genética , Hormona del Crecimiento/metabolismo , Hormonas Hipotalámicas/genética , Hormonas Hipotalámicas/metabolismo , Melaninas/genética , Melaninas/metabolismo , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , Oncorhynchus mykiss/genética , Hormonas Hipofisarias/genética , Hormonas Hipofisarias/metabolismo , Proopiomelanocortina/genética , Proopiomelanocortina/metabolismo , Prolactina/genética , Prolactina/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismoRESUMEN
Bioactive peptide drugs hold promise for therapeutic application due to their high potency and selectivity but display short plasma half-life. Examination of selected naturally occurring peptide hormones derived from proteolytic cleavage of the proopiomelanocortin (POMC) precursor lead to the identification of significant plasma-stabilizing properties of a 12-amino acid serine-rich orphan sequence NSSSSGSSGAGQ in human γ3-melanocyte-stimulating hormone (MSH) that is homologous to previously discovered NSn GGH (n = 4-24) sequences in owls. Notably, transfer of this sequence to des-acetyl-α-MSH and the therapeutically relevant peptide hormones neurotensin and glucagon-like peptide-1 likewise enhance their plasma stability without affecting receptor signaling. The stabilizing effect of the sequence module is independent of plasma components, suggesting a direct effect in cis. This natural sequence module may provide a possible strategy to enhance plasma stability, complementing existing methods of chemical modification.
Asunto(s)
Receptor del Péptido 1 Similar al Glucagón/química , Hormonas Estimuladoras de los Melanocitos/química , Proteínas de la Membrana/química , Proopiomelanocortina/química , Receptor de Melanocortina Tipo 1/química , Secuencia de Aminoácidos , AMP Cíclico/metabolismo , Expresión Génica , Receptor del Péptido 1 Similar al Glucagón/sangre , Receptor del Péptido 1 Similar al Glucagón/genética , Células HEK293 , Humanos , Hormonas Estimuladoras de los Melanocitos/sangre , Hormonas Estimuladoras de los Melanocitos/genética , Proteínas de la Membrana/sangre , Proteínas de la Membrana/genética , Péptidos/sangre , Péptidos/síntesis química , Proopiomelanocortina/sangre , Proopiomelanocortina/genética , Isoformas de Proteínas/sangre , Isoformas de Proteínas/química , Isoformas de Proteínas/genética , Estabilidad Proteica , Receptor de Melanocortina Tipo 1/sangre , Receptor de Melanocortina Tipo 1/genética , Receptores de Neurotensina/sangre , Receptores de Neurotensina/genética , Alineación de Secuencia , Homología de Secuencia de Aminoácido , Transducción de SeñalRESUMEN
To evaluate the association of the melanotropic peptides and their receptors for morphological color change, we investigated the effects of changes in background color, between white and black, on xanthophore density in the scales and expression levels of genes for hormonal peptides and corresponding receptors (MCH-R2, MC1R, and MC5R) in goldfish (Carassius auratus). The xanthophore density in both dorsal and ventral scales increased after transfer from a white to black background. However, xanthophore density in dorsal scales increased after transfer from a black to white background, and that of ventral scales decreased after transfer from a black to black background, which served as the control. In the white-reared fish, melanin-concentrating hormone (mch) mRNA content in the brain was higher than that in black-reared fish, whereas proopiomelanocortin a (pomc-a) mRNA content in the pituitary was lower than that in the black-reared fish. Agouti-signaling protein (asp) mRNA was detected in the ventral skin but not in the dorsal skin. No difference was observed in the asp mRNA content between fish reared in white or black background, suggesting that ASP might not be associated with background color adaptation. In situ hybridization revealed that both mc1r and mc5r were expressed in the xanthophores in scales. The mRNA content of mc1r in scales did not always follow the background color change, whereas those of mc5r decreased in the white background and increased in the black background, suggesting that mc5r might be a major factor reinforcing the function of MSH in morphological color changes. White backgrounds increased mch mRNA content in the brain, but decreased mch-r2 mRNA content in the scales. These altered expression levels of melanotropin receptors might affect reactivity to melanotropins through long-term adaptation to background color.
Asunto(s)
Regulación de la Expresión Génica , Carpa Dorada/genética , Hormonas Estimuladoras de los Melanocitos/genética , Pigmentación/genética , Receptores de la Hormona Hipofisaria/genética , Escamas de Animales/metabolismo , Animales , Encéfalo/metabolismo , Color , Carpa Dorada/metabolismo , Hormonas Hipotalámicas/genética , Hormonas Hipotalámicas/metabolismo , Melaninas/genética , Melaninas/metabolismo , Hormonas Estimuladoras de los Melanocitos/metabolismo , Hormonas Hipofisarias/genética , Hormonas Hipofisarias/metabolismo , Proopiomelanocortina/genética , Proopiomelanocortina/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Receptores de la Hormona Hipofisaria/metabolismo , Piel/metabolismoRESUMEN
The H (hypothalamic)-P (pituitary)-I (interrenal) axis is critical in the stress response and other activities of fish. To further investigate cadmium (Cd) toxicity on the H-P-I axis and to identify its potential regulatory genes in fish, the adult female rare minnows (Gobiocypris rarus) were exposed to subchronic (5weeks) levels of waterborne Cd in the present study. This kind of treatment caused dose-dependent decline in fish growth, with significance in the high dose group (100µg/L). Correspondingly, low dose (5-50µg/L) waterborne Cd disrupted the endocrine system of H-P-I axis just at the secretion level, while high dose Cd disrupted both the secretion and synthesis of cortisol and its downstream signals in rare minnows, revealed by the significantly upregulation and positive correlation of corticosteroidogenic genes including MC2R, StAR, CYP11A1, and CYP11B1 in the kidney (including the interrenal tissue) (P<0.05), and the significant alteration of Glcci1, Hsp90AA and Hsp90AB in the hepatopancreas, gill and intestine as well (P<0.05). The expression of Glcci1 was significantly decreased in hepatopancreas, gill and intestine of tested fish following treatment, and its positive correlation with GR (Glucocorticoid receptor) suggested its potential regulation on the cortisol and/or H-P-I axis in fish. The expression of FKBP5 in the intestine was positively and significantly correlated with that of Hsp90AA (P<0.05), and the Hsp90AB transcript in the hepatopancreas was positively correlated with that of Hsp90AA (P<0.05), which indicated that Hsp90AA and Hsp90AB were more likely to serve as cofactors of GR and FKBP5 in response to Cd exposure.
Asunto(s)
Cloruro de Cadmio/toxicidad , Cyprinidae/fisiología , Sistema Hipotálamo-Hipofisario/efectos de los fármacos , Glándula Interrenal/efectos de los fármacos , Hormona Adrenocorticotrópica/genética , Hormona Adrenocorticotrópica/metabolismo , Animales , Cloruro de Cadmio/administración & dosificación , Hormona Liberadora de Corticotropina/genética , Hormona Liberadora de Corticotropina/metabolismo , Esquema de Medicación , Femenino , Regulación de la Expresión Génica/efectos de los fármacos , Hidrocortisona/genética , Hidrocortisona/metabolismo , Sistema Hipotálamo-Hipofisario/fisiología , Glándula Interrenal/fisiología , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , ARN Mensajero/genética , ARN Mensajero/metabolismo , Proteínas de Unión a Tacrolimus/genética , Proteínas de Unión a Tacrolimus/metabolismo , Contaminantes Químicos del Agua/toxicidadRESUMEN
The remarkable conservation of the primary structures and anatomical location of dogfish α-melanocyte-stimulating hormone (MSH), corticotrophin-like intermediate lobe peptide (CLIP) and adrenocorticotrophic hormone (ACTH) compared with mammals reinforced the tissue-specific processing hypothesis of ACTH peptides in the pituitary gland. The cloning of dogfish pro-opiomelanocortin (POMC) led to the identification of δ-MSH and simultaneously revealed the high conservation of the γ-MSH sequence during evolution. These studies have also shown that ß-MSH is much less conserved during evolution and in some species is not even processed from ß-LPH. Human pro-γ-MSH potentiates the corticosteroidogenic activity of ACTH and peptides generated from its N-terminal, in particular big-γ-MSH, appear to have adrenal mitogenic activity. Human big-γ-MSH (from the zona intermedia) may also cause the adrenache. The review finishes with a cautionary note with regard to the misdiagnosis of the ectopic ACTH syndrome in which partial processing of ACTH can result in large concentrations of α-MSH and CLIP, which can interfere in the performance of two-site immunoassays, and the problem of the correct disulphide bridge arrangement in synthetic N-POMC peptides is also discussed.
Asunto(s)
Hormona Adrenocorticotrópica/aislamiento & purificación , Hormonas Estimuladoras de los Melanocitos/aislamiento & purificación , Proopiomelanocortina/aislamiento & purificación , Síndrome de ACTH Ectópico/sangre , Síndrome de ACTH Ectópico/metabolismo , Glándulas Suprarrenales/metabolismo , Hormona Adrenocorticotrópica/sangre , Hormona Adrenocorticotrópica/química , Hormona Adrenocorticotrópica/genética , Animales , Péptido de la Porción Intermedia de la Adenohipófisis Similar a la Corticotropina/química , Péptido de la Porción Intermedia de la Adenohipófisis Similar a la Corticotropina/genética , Péptido de la Porción Intermedia de la Adenohipófisis Similar a la Corticotropina/aislamiento & purificación , Historia del Siglo XX , Humanos , Hormonas Estimuladoras de los Melanocitos/sangre , Hormonas Estimuladoras de los Melanocitos/química , Hormonas Estimuladoras de los Melanocitos/genética , Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT)/sangre , Hipersecreción de la Hormona Adrenocorticotrópica Pituitaria (HACT)/metabolismo , Hipófisis/metabolismo , Proopiomelanocortina/química , Proopiomelanocortina/genética , Proopiomelanocortina/historia , Isoformas de Proteínas , alfa-MSH/química , alfa-MSH/genética , alfa-MSH/aislamiento & purificación , betaendorfina/química , betaendorfina/genética , betaendorfina/aislamiento & purificaciónRESUMEN
The melanocortin system is a neuroendocrine machinery that has been associated with phenotypic diversification in a number of vertebrate lineages. Central to the highly pleiotropic melanocortin system is the pro-opiomelanocortin (pomc) gene family, a family of pre-prohormones that each give rise to melanocyte stimulating hormone (MSH), adrenocorticotropic releasing hormone (ACTH), ß-lipotropin hormone, and ß-endorphin. Here we examine the structure, tissue expression profile, and pattern of cis transcriptional regulation of the three pomc paralogs (α1, α2, and ß) in the model cichlid fish Astatotilapia burtoni and other cichlids, teleosts, and mammals. We found that the hormone-encoding regions of pomc α1, pomc α2 and pomc ß are highly conserved, with a few notable exceptions. Surprisingly, the pomc ß gene of cichlids and pomacentrids (damselfish) encodes a novel melanocortin peptide, ε-MSH, as a result of a tandem duplication of the segment encoding ACTH. All three genes are expressed in the brain and peripheral tissues, but pomc α1 and α2 show a more spatially restricted expression profile than pomc ß. In addition, the promoters of each pomc gene have diverged in nucleotide sequence, which may have facilitated the diverse tissue-specific expression profiles of these paralogs across species. Increased understanding of the mechanisms regulating pomc gene expression will be invaluable to the study of pomc in the context of phenotypic evolution.
Asunto(s)
Evolución Biológica , Proteínas de Peces/genética , Regulación de la Expresión Génica , Familia de Multigenes , Proopiomelanocortina/genética , Elementos Reguladores de la Transcripción/genética , Hormona Adrenocorticotrópica/genética , Secuencia de Aminoácidos , Animales , Peces/genética , Hormonas Estimuladoras de los Melanocitos/genética , Datos de Secuencia Molecular , Especificidad de Órganos , Filogenia , Regiones Promotoras Genéticas/genética , Homología de Secuencia de AminoácidoRESUMEN
The conventional chemotherapeutic treatment of malignant melanoma still remains poorly efficient in most cases. Thus the use of specific features of these tumors for development of new therapeutic modalities is highly needed. Melanocortin 1 receptor (MC1R) overexpression on the cell surface of the vast majority of human melanomas, making MC1R a valuable marker of these tumors, is one of these features. Naturally, MC1R plays a key role in skin protection against damaging ultraviolet radiation by regulating eumelanin production. MC1R activation is involved in regulation of melanocyte cell division. This article reviews the peculiarities of regulation and expression of MC1R, melanocytes, and melanoma cells, along with the possible connection of MC1R with signaling pathways regulating proliferation of tumor cells. MC1R is a cell surface endocytic receptor, thus considered perspective for diagnostics and targeted drug delivery. A number of new therapeutic approaches that utilize MC1R, including endoradiotherapy with Auger electron and α- and ß-particle emitters, photodynamic therapy, and gene therapy are now being developed.
Asunto(s)
Melanoma/metabolismo , Receptor de Melanocortina Tipo 1/metabolismo , Animales , Antineoplásicos/química , Antineoplásicos/uso terapéutico , Endocitosis , Humanos , Hormonas Estimuladoras de los Melanocitos/química , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , Melanocitos/metabolismo , Melanoma/diagnóstico , Melanoma/terapia , Radiofármacos/uso terapéutico , Receptor de Melanocortina Tipo 1/antagonistas & inhibidores , Proteínas Recombinantes/biosíntesis , Proteínas Recombinantes/química , Proteínas Recombinantes/uso terapéutico , Transducción de SeñalRESUMEN
OBJECTIVE: To facilitate the targeting to inflammation sites of small anti-inflammatory peptides, with short half-lives, by fusion with the latency-associated peptide (LAP) of transforming growth factor ß1 through a cleavable matrix metalloproteinase (MMP) linker. This design improves efficacy, overcoming the limitations to their clinical use. METHODS: We generated latent forms of vasoactive intestinal peptide (VIP), α-melanocyte-stimulating hormone (MSH) and γ(3)MSH by fusion to LAP through an MMP cleavage site using recombinant DNA technology. The biological activities of these latent therapeutics were studied in vivo using monosodium urate (MSU)-induced peritonitis and collagen-induced arthritis (CIA) models. We assessed gene therapy and purified protein therapy. RESULTS: The recruitment of the polymorphonuclear cells induced by MSU injection into mouse peritoneal cavity was reduced by 35% with γ(3)MSH (1 nmol), whereas administration of a much lower dose of purified latent LAP-MMP-γ(3)MSH (0.03 nmol) attenuated leucocyte influx by 50%. Intramuscular gene delivery of plasmids coding LAP-MMP-VIP and LAP-MMP-αMSH at disease onset reduced the development of CIA compared with LAP-MMP, which does not contain any therapeutic moiety. Histological analysis confirmed a significantly lower degree of inflammation, bone and cartilage erosion in groups treated with LAP-MMP-VIP or LAP-MMP-αMSH. Antibody titres to collagen type II and inflammatory cytokine production were also reduced in these two groups. CONCLUSION: Incorporation of small anti-inflammatory peptides within the LAP shell and delivered as recombinant protein or through gene therapy can control inflammatory and arthritic disease. This platform delivery can be developed to control human arthritides and other autoimmune diseases.
Asunto(s)
Antiinflamatorios no Esteroideos/uso terapéutico , Artritis Experimental/terapia , Hormonas Estimuladoras de los Melanocitos/uso terapéutico , Fragmentos de Péptidos/uso terapéutico , Peritonitis/terapia , Proteínas Recombinantes de Fusión/uso terapéutico , Factor de Crecimiento Transformador beta/uso terapéutico , Péptido Intestinal Vasoactivo/uso terapéutico , Animales , Antiinflamatorios no Esteroideos/farmacocinética , Artritis Experimental/tratamiento farmacológico , Artritis Experimental/metabolismo , Artritis Experimental/patología , Citocinas/sangre , Sistemas de Liberación de Medicamentos , Diseño de Fármacos , Evaluación Preclínica de Medicamentos/métodos , Terapia Genética/métodos , Semivida , Masculino , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/farmacocinética , Ratones , Ratones Endogámicos DBA , Fragmentos de Péptidos/genética , Fragmentos de Péptidos/farmacocinética , Peritonitis/tratamiento farmacológico , Peritonitis/metabolismo , Proteínas Recombinantes de Fusión/farmacocinética , Distribución Tisular , Resultado del Tratamiento , Péptido Intestinal Vasoactivo/genética , Péptido Intestinal Vasoactivo/farmacocinéticaRESUMEN
It is well known that endocannabinoids play an important role in the regulation of food intake and body weight. Endocannabinoids and cannabinoid receptors are found in the hypothalamus and brainstem, which are central areas involved in the control of food intake and energy expenditure. Activation of these areas is related to hypophagia observed during inflammatory stimulus. This study investigated the effects of cannabinoid (CB1) receptor blockade on lipopolysaccharide (LPS)-induced hypophagia. Male Wistar rats were pretreated with rimonabant (10 mg/kg, by gavage) or vehicle; 30 min later they received an injection of either LPS (100 µg/kg, intraperitoneal) or saline. Food intake, body weight, corticosterone response, CRF and CART mRNA expression, Fos-CRF and Fos-α-MSH immunoreactivity in the hypothalamus and Fos-tyrosine hydroxylase (TH) immunoreactivity in the brainstem were evaluated. LPS administration decreased food intake and body weight gain and increased plasma corticosterone levels and CRF mRNA expression in the PVN. We also observed an increase in Fos-CRF and Fos-TH double-labeled neurons after LPS injection in vehicle-pretreated rats, with no changes in CART mRNA or Fos-α-MSH immunoreactive neurons in the ARC. In saline-treated animals, rimonabant pretreatment decreased food intake and body weight gain but did not modify hormone response or Fos expression in the hypothalamus and brainstem compared with vehicle-pretreated rats. Rimonabant pretreatment potentiated LPS-induced hypophagia, body weight loss and Fos-CRF and Fos-TH expressing neurons. Rimonabant did not modify corticosterone, CRF mRNA or Fos-α-MSH responses in rats treated with LPS. These data suggest that the endocannabinoid system, mediated by CB1 receptors, modulates hypothalamic and brainstem circuitry underlying the hypophagic effect during endotoxemia to prevent an exaggerated food intake decrease. This article is part of a Special Issue entitled 'Central Control of Food Intake'.
Asunto(s)
Anorexia Nerviosa/patología , Tronco Encefálico/patología , Hormona Liberadora de Corticotropina/metabolismo , Hipotálamo/patología , Neuronas/enzimología , Receptor Cannabinoide CB1/antagonistas & inhibidores , Tirosina 3-Monooxigenasa/metabolismo , Animales , Anorexia Nerviosa/etiología , Peso Corporal/efectos de los fármacos , Recuento de Células , Corticosterona/sangre , Hormona Liberadora de Corticotropina/genética , Modelos Animales de Enfermedad , Ingestión de Alimentos/efectos de los fármacos , Endotoxemia/inducido químicamente , Endotoxemia/complicaciones , Regulación de la Expresión Génica/efectos de los fármacos , Hipotálamo/efectos de los fármacos , Lipopolisacáridos/toxicidad , Masculino , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , Microdiálisis , Neuronas/efectos de los fármacos , Proteínas Oncogénicas v-fos/genética , Proteínas Oncogénicas v-fos/metabolismo , Piperidinas/farmacología , Pirazoles/farmacología , ARN Mensajero/metabolismo , Radioinmunoensayo , Ratas , Ratas Wistar , Rimonabant , Factores de TiempoRESUMEN
Cyclic AMP (cAMP) is a ubiquitous second messenger that regulates a variety of biological processes. The magnitude and duration of cAMP expression are regulated by both production and hydrolysis. Melanocyte-stimulating hormone (MSH) plays a crucial role in pigment cell differentiation via cAMP-regulated expression of the master transcription factor MITF. We report the identification of phosphodiesterase 4D3 as a direct target of the MSH/cAMP/MITF pathway. This creates a negative feedback loop that induces refractoriness to chronic stimulation of the cAMP pathway in melanocytes. This homeostatic pathway highlights a potent mechanism controlling melanocyte differentiation that may be amenable to pharmacologic manipulation for skin cancer prevention.
Asunto(s)
Diferenciación Celular , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4/metabolismo , Melanocitos/metabolismo , Factor de Transcripción Asociado a Microftalmía/metabolismo , Animales , Línea Celular Tumoral , Células Cultivadas , Colforsina/farmacología , AMP Cíclico/metabolismo , Fosfodiesterasas de Nucleótidos Cíclicos Tipo 4/genética , Retroalimentación Fisiológica , Homeostasis , Humanos , Immunoblotting , Recién Nacido , Masculino , Melaninas/metabolismo , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , Melanocitos/citología , Ratones , Ratones Endogámicos C57BL , Factor de Transcripción Asociado a Microftalmía/genética , Inhibidores de Fosfodiesterasa 4 , Inhibidores de Fosfodiesterasa/farmacología , Unión Proteica , Interferencia de ARN , Rolipram/farmacología , Transducción de Señal , Piel/efectos de los fármacos , Piel/metabolismoAsunto(s)
Espasmos Infantiles/etiología , 1-Alquil-2-acetilglicerofosfocolina Esterasa/genética , Aberraciones Cromosómicas , Proteínas de Dominio Doblecortina , Humanos , Lactante , Recién Nacido , Canales Iónicos/fisiología , Hormonas Estimuladoras de los Melanocitos/genética , Proteínas Asociadas a Microtúbulos/genética , Mutación , Neuronas/fisiología , Neuropéptidos/genética , Espasmos Infantiles/genética , Proteína 1 del Complejo de la Esclerosis Tuberosa , Proteína 2 del Complejo de la Esclerosis Tuberosa , Proteínas Supresoras de Tumor/genéticaRESUMEN
OBJECTIVE: To study the cytotoxicity of recombinate toxin MSH-Ang to Hep-2. METHOD: The depurated MSH-Ang were applied in cytotoxicity experiment, and the growth inhibiting action to laryngeal carcinoma cell Hep-2 were observed. RESULT: Recombination protein inhibited the growth of laryngeal carcinoma cell Hep-2, and its inhibiting action enhanced and corpuscular mortality rate increased along with the concentration increasing. CONCLUSION: Recombinant toxin MSH-Ang can not only take special effect in tumors with high MSHR, but also target to many other popular tumors.
Asunto(s)
Angiopoyetinas/farmacología , Hormonas Estimuladoras de los Melanocitos/farmacología , Angiopoyetinas/genética , Línea Celular Tumoral , Ingeniería Genética , Humanos , Neoplasias Laríngeas , Hormonas Estimuladoras de los Melanocitos/genética , Recombinación GenéticaRESUMEN
Prior studies of mRNA expression, protein expression, and pathway metabolite levels have implicated dysregulation of the kynurenine pathway in the etiology of schizophrenia and bipolar disorder. Here we investigate whether genes involved in kynurenine pathway regulation might interact with genes that respond to kynurenine metabolites, to enhance risk for these psychiatric phenotypes. Candidate genes were selected from prior studies of genetic association, gene expression profiling and animal models. A single nucleotide polymorphism (SNP) in each of six genes, TDO2, HM74, HM74A, MCHR1, MCHR2 and MC5R, was tested for association with phenotype (475 Caucasians, 88 African Americans with schizophrenia; 97 Caucasians, 3 African Americans with bipolar disorder; 191 Caucasian, 49 African American controls). An A allele in HM74 was significantly associated with schizophrenia and with schizophrenia plus bipolar disorder combined, odds ratios (OR) of 1.48, p=0.011 and 1.50, p=0.007, respectively. Augmentation of disease risk was found for the complex genotype HM74[A,any]+MCHR1[T,any]+MCHR2[C,any] which conferred an OR maximal for the combined diagnostic category of schizophrenia plus bipolar disorder (1.70, p=0.003), carried by 30% of the cases. TDO2[CC]+MC5R[G, any]+MCHR2[GC] conferred an OR maximal for schizophrenia alone (4.84, p=0.005), carried by 8% of schizophrenia cases. The combined risk posed by these related, complex genotypes is greater than any identified single locus and may derive from co-regulation of the kynurenine pathway by interacting genes, a lack of adequate melanotropin-controlled sequestration of the kynurenine-derived pigments, or the production of melanotropin receptor ligands through kynurenine metabolism.
Asunto(s)
Trastorno Bipolar/genética , Predisposición Genética a la Enfermedad/genética , Quinurenina/genética , Hormonas Estimuladoras de los Melanocitos/genética , Polimorfismo de Nucleótido Simple/genética , Esquizofrenia/genética , Adulto , Negro o Afroamericano , Anciano , Anciano de 80 o más Años , Trastorno Bipolar/metabolismo , Bases de Datos Genéticas/estadística & datos numéricos , Femenino , Frecuencia de los Genes , Genotipo , Humanos , Quinurenina/metabolismo , Modelos Logísticos , Masculino , Hormonas Estimuladoras de los Melanocitos/metabolismo , Persona de Mediana Edad , Oportunidad Relativa , Cambios Post Mortem , Receptores Acoplados a Proteínas G/genética , Receptores Nicotínicos/genética , Reproducibilidad de los Resultados , Esquizofrenia/metabolismo , Transducción de Señal/genética , Triptófano Oxigenasa/genética , Población Blanca/genética , Adulto JovenRESUMEN
Melanocyte-stimulating hormone (MSH) is generated from a precursor protein, proopiomelanocortin (POMC), mainly in the pituitary. The barfin flounder, Verasper moseri, expresses three different POMC genes (Pomc), among which Pomc-c is also expressed in the skin. Herein, we characterized the biological significance of POMC and MSH produced in barfin flounder skin. The reverse transcription polymerase chain reaction showed the expression of Pomc-c in isolated non-chromatophoric dermal cells. Mass spectrometry analyses of fractions of skin extract separated by high-performance liquid chromatography revealed the presence of a peptide with a molecular mass corresponding to Des-acetyl (Ac)-alpha-MSH-C derived from POMC-C. These results indicate that, in addition to endocrine functions, MSH in barfin flounder is associated with skin pigmentation via paracrine mechanisms. On the other hand, in vitro studies showed that Des-Ac-alpha-MSH-C dispersed pigments in both melanophores and xanthophores. These functions are similar to those of Des-Ac-alpha-MSH, which differs from Des-Ac-alpha-MSH-C only at the C-terminus, generated from POMC-A and -B. Alpha-MSH, which has an acetyl group at the N-terminus, led to pigment dispersion in xanthophores, but showed no effect in melanophores. A series of bioassays indicated that acetylation enhances MSH activity in xanthophores, but inhibits it in melanophores, suggesting that receptors for MSHs expressed in xanthophores and melanophores are different from each other.
Asunto(s)
Lenguado/metabolismo , Hormonas Estimuladoras de los Melanocitos/fisiología , Hipófisis/metabolismo , Piel/metabolismo , Acetilación , Animales , Cromatografía Líquida de Alta Presión , Espectrometría de Masas , Hormonas Estimuladoras de los Melanocitos/genética , Melanóforos/metabolismo , Proopiomelanocortina/genética , Proopiomelanocortina/fisiología , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Pigmentación de la Piel/fisiologíaRESUMEN
Human genetic data indicate impaired synthesis or processing of POMC results in obesity. We have used a mouse model of POMC deficiency (Pomc null) to explore the role of POMC-derived peptides in energy homeostasis. The phenotype of Pomc null mice recapitulates the clinical syndrome seen in humans congenitally lacking POMC. Loss of only one copy of the Pomc gene is sufficient to render mice susceptible to the effects of high fat feeding, emphasizing an important gene-environment interaction predisposing to obesity. Our studies indicate that POMC-derived peptides have influences on the response to a high fat diet, including a major influence on the dietary preference for fat. Pomc null mice are unusual in that obesity and hyperphagia develop in the absence of circulating glucocorticoid (GC). To investigate the interaction between GCs and the melanocortin system, we administered corticosterone to Pomc null mice. They appear hypersensitive to the adverse metabolic effects of GCs, developing hypertension, an exacerbation of both hyperphagia and obesity and a profound insulin resistance. GC treatment of Pomc null mice significantly increases the expression of the melanocortin antagonist agouti-related protein (AgRP). On-going studies in mice lacking both AgRP and Pomc will determine whether the metabolic phenotype seen with this GC therapy is due to a lack of melanocortin peptide, the unopposed action of AgRP or a combination of both.
Asunto(s)
Metabolismo Energético , Homeostasis , Péptidos/metabolismo , Proopiomelanocortina/metabolismo , Animales , Dieta , Alimentos , Preferencias Alimentarias , Glucocorticoides/metabolismo , Humanos , Melanocortinas/metabolismo , Hormonas Estimuladoras de los Melanocitos/genética , Hormonas Estimuladoras de los Melanocitos/metabolismo , Péptidos/genética , Proopiomelanocortina/genética , Isoformas de Proteínas/genética , Isoformas de Proteínas/metabolismoRESUMEN
Neuropeptides with the Arg-Phe-amide motif at their C termini (RFamide peptides) were identified in the brains of several vertebrates, and shown to have important physiological roles in neuroendocrine, behavioral, sensory, and autonomic functions. The present study identified RFamide peptides, which are teleost prolactin-releasing peptide (PrRP) homologs, in the sea lamprey, Petromyzon marinus and characterized their effect on the release of pituitary hormones in vitro. Two RFamide peptides (RFa-A and RFa-B) were isolated from an acid extract of sea lamprey brain, including hypothalamus by Sep-Pak C18 cartridge, affinity chromatography using anti-salmon PrRP serum, and reverse-phase HPLC on an ODS-120T column. Amino acid (aa) sequences and mass spectrometric analyses revealed that RFa-A and RFa-B consist of 25 and 20 aa, respectively, and have 75% sequence identity within the C-terminal 20 aa. The RFa-B cDNA encoding a preprohormone of 142 aa was cloned from the lamprey brain, and the deduced aa sequence from positions 48-67 was identical to the sequence of RFa-B. However, the preprohormone does not include an aa sequence similar to the RFa-A sequence. Cell bodies, which were immunoreactive to anti-salmon PrRP serum, were located in the periventricular arcuate nucleus, ventral part of the hypothalamus, and immunoreactive fibers were abundant from the hypothalamus to the brain. A small number of immunoreactive fibers were detected in the dorsal half of the rostral pars distalis of the pituitary, close to the GH-producing cells. In addition, anti-salmon PrRP immunoreactivities were observed in the pars intermedia, corresponding to melanotropin cells. Likewise, signal of RFa-B mRNA was detected not only in the brain but also in the pars intermedia. The synthetic RFa-A and -B inhibited GH mRNA expression in a dose-dependent fashion in vitro, which is comparable to the inhibitory effect of teleost PrRP on GH release. Both RFa-A and -B also inhibited the expression of proopiomelanotropin mRNA, but no effects were observed in the expression of proopiocortin and gonadotropin beta mRNAs. The results indicate that RFamide peptides, which are teleost PrRP homologs, are present in the hypothalamus and pituitary of sea lamprey, and may be physiologically involved in the inhibition of GH and melanotropin release in the sea lamprey pituitary.
Asunto(s)
Hormona del Crecimiento/genética , Hormonas Estimuladoras de los Melanocitos/genética , Neuropéptidos/metabolismo , Petromyzon/fisiología , Hipófisis/fisiología , Secuencia de Aminoácidos , Animales , Secuencia de Bases , Encéfalo/fisiología , Clonación Molecular , ADN Complementario , Femenino , Expresión Génica/fisiología , Gonadotropinas Hipofisarias/genética , Técnicas In Vitro , Masculino , Datos de Secuencia Molecular , Neuropéptidos/genética , Proopiomelanocortina/genética , ARN Mensajero/metabolismoRESUMEN
To determine whether long-term melanocortinergic activation can attenuate the metabolic effects of a high fat diet, mice overexpressing an NH(2)-terminal POMC transgene that includes alpha- and gamma(3)-MSH were studied on either a 10% low-fat diet (LFD) or 45% high-fat diet (HFD). Weight gain was modestly reduced in transgenic (Tg-MSH) male and female mice vs. wild type (WT) on HFD (P < 0.05) but not LFD. Substantial reductions in body fat percentage were found in both male and female Tg-MSH mice on LFD (P < 0.05) and were more pronounced on HFD (P < 0.001). These changes occurred in the absence of significant feeding differences in most groups, consistent with effects of Tg-MSH on energy expenditure and partitioning. This is supported by indirect calorimetry studies demonstrating higher resting oxygen consumption and lower RQ in Tg-MSH mice on the HFD. Tg-MSH mice had lower fasting insulin levels and improved glucose tolerance on both diets. Histological and biochemical analyses revealed that hepatic fat accumulation was markedly reduced in Tg-MSH mice on the HFD. Tg-MSH also attenuated the increase in corticosterone induced by the HFD. Higher levels of Agrp mRNA, which might counteract effects of the transgene, were measured in Tg-MSH mice on LFD (P = 0.02) but not HFD. These data show that long-term melanocortin activation reduces body weight, adiposity, and hepatic fat accumulation and improves glucose metabolism, particularly in the setting of diet-induced obesity. Our results suggest that long-term melanocortinergic activation could serve as a potential strategy for the treatment of obesity and its deleterious metabolic consequences.
Asunto(s)
Dieta Aterogénica , Hormonas Estimuladoras de los Melanocitos/genética , Obesidad/genética , Animales , Composición Corporal/genética , Peso Corporal/genética , Ingestión de Alimentos/genética , Femenino , Regulación de la Expresión Génica , Glucosa/metabolismo , Homeostasis/genética , Lípidos/análisis , Hígado/anatomía & histología , Hígado/química , Masculino , Ratones , Ratones Endogámicos C57BL , Ratones Transgénicos , Obesidad/etiología , Obesidad/metabolismo , Tamaño de los Órganos/genética , Consumo de Oxígeno/genética , Pruebas de Función RespiratoriaRESUMEN
Proopiomelanocortin (POMC) is a common precursor of melanocortin (MC), the collective term for adrenocorticotropic hormone (ACTH) and melanophore-stimulating hormone (MSH), and of beta-endorphin (beta-END). Over the past decade, considerable progress has been made in the analysis of the POMC gene from a board taxonomic group of vertebrates and invertebrates. The results suggest that three MSHs (alpha-, beta-, and gamma-MSH) and a single END were established in ancestral invertebrates. Thereafter, unequal crossing over may have resulted in class-specific numbers of MSH segments during the radiation of fish. Moreover, duplication of the entire POMC gene may have led to the differentiation of POMC as shown in lampreys; one of the two subtypes is a precursor for ACTH and beta-END, the other is a precursor for two forms of MSH and the other form of beta-END. On the other hand, at least five subtypes of MC receptor (MCR) have been observed in fish. These are G-protein-coupled receptors with seven transmembrane domains. The ancestral MCR is suggested to have appeared before vertebrates, and then MCRs may have diverged by genome duplication and local duplication of each receptor gene during the evolution of vertebrates. They are distributed in many tissues in rather a subtype-specific manner and are responsible for a variety of biological functions. Thus, MC systems may have diverged by producing structurally different MC peptides from POMC and expressing MCR subtypes differing in ligand selectivity in a variety of tissues.